Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Pulmonary/Respiratory Diseases | Family Medicine
 Disease Category: Non-Small Cell Lung Cancer
Location: United States, ND

Trial Information

Non-Small Cell Lung Cancer

First-line treatment for patients with non-squamous non-small cell lung cancer

Patient Inclusion Criteria:

  • Confirmed diagnosis, at least one measurable target lesion, 18+ years of age, life expectancy of >12 weeks

Patient Exclusion Criteria:

  • Small cell or carcinoid lung cancer patients are ineligible, untreated brain metastases, history of active malignancy in the past 3 years

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131
Email: tdavis.legacy@midconetwork.com

View Map

Research Center Information: Legacy Pharma Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.